These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Oxytocin discontinuation during active labor in women who undergo labor induction.
    Author: Diven LC, Rochon ML, Gogle J, Eid S, Smulian JC, Quiñones JN.
    Journal: Am J Obstet Gynecol; 2012 Dec; 207(6):471.e1-8. PubMed ID: 22989707.
    Abstract:
    OBJECTIVE: The purpose of this study was to determine whether there is an increase in the cesarean delivery rate in women who undergo induction when oxytocin is discontinued in the active phase of labor. STUDY DESIGN: We conducted a prospective randomized controlled trial of women who underwent induction of labor at term; they were assigned randomly to either routine oxytocin use (routine) or oxytocin discontinuation (DC) once in active labor. Analysis was by intention to treat. RESULTS: Two hundred fifty-two patients were eligible for study analysis: 127 patients were assigned randomly to the routine group and 125 patients were assigned randomly to the DC group. Cesarean delivery rate was similar between the groups (routine, 25.2% [n = 32] vs the DC group, 19.2% [n = 24]; P = .25). There was a higher chorioamnionitis rate and slightly longer active phase in those women who were assigned to the DC group. In adjusted analysis, the rate of chorioamnionitis was not different by randomization group but was explained by the duration of membrane rupture and intrauterine pressure catheter placement. CONCLUSION: Discontinuation of oxytocin in active labor after labor induction does not increase the cesarean delivery rate significantly.
    [Abstract] [Full Text] [Related] [New Search]